Ribeiro C, Ladeira I, Gaio A R, Brito M C
Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Portugal.
Rev Port Pneumol. 2013 Nov-Dec;19(6):252-9. doi: 10.1016/j.rppneu.2012.09.006. Epub 2013 Jul 10.
The site-of-care decision is one of the most important factors in the management of patients with community-acquired pneumonia. The severity scores are validated prognostic tools for community-acquired pneumonia mortality and treatment site decision. The aim of this paper was to compare the discriminatory power of four scores - the classic PSI and CURB65 ant the most recent SCAP and SMART-COP - in predicting major adverse events: death, ICU admission, need for invasive mechanical ventilation or vasopressor support in patients admitted with pneumococcal pneumonia.
A five year retrospective study of patients admitted for pneumococcal pneumonia. Patients were stratified based on admission data and assigned to low-, intermediate-, and high-risk classes for each score. Results were obtained comparing low versus non-low risk classes.
We studied 142 episodes of hospitalization with 2 deaths and 10 patients needing mechanical ventilation and vasopressor support. The majority of patients were classified as low risk by all scores - we found high negative predictive values for all adverse events studied, the most negative value corresponding to the SCAP score. The more recent scores showed better accuracy for predicting ICU admission and need for ventilation or vasopressor support (mostly for the SCAP score with higher AUC values for all adverse events).
The rate of all adverse outcomes increased directly with increasing risk class in all scores. The new gravity scores appear to have a higher discriminatory power in all adverse events in our study, particularly, the SCAP score.
护理地点的决策是社区获得性肺炎患者管理中最重要的因素之一。严重程度评分是用于预测社区获得性肺炎死亡率和治疗地点决策的经过验证的预后工具。本文的目的是比较四个评分——经典的肺炎严重指数(PSI)和CURB65以及最新的重症社区获得性肺炎(SCAP)和简化版序贯器官衰竭评估(SMART-COP)——在预测主要不良事件方面的区分能力:患有肺炎球菌肺炎的患者出现死亡、入住重症监护病房(ICU)、需要有创机械通气或血管活性药物支持。
对因肺炎球菌肺炎入院的患者进行了一项为期五年的回顾性研究。根据入院数据对患者进行分层,并为每个评分分为低、中、高风险类别。通过比较低风险类别与非低风险类别得出结果。
我们研究了142例住院病例,其中2例死亡,10例患者需要机械通气和血管活性药物支持。所有评分都将大多数患者归类为低风险——我们发现所有研究的不良事件都有较高的阴性预测值,最低的阴性预测值对应SCAP评分。最新的评分在预测入住ICU以及需要通气或血管活性药物支持方面显示出更好的准确性(主要是SCAP评分,所有不良事件的曲线下面积值更高)。
在所有评分中,所有不良结局的发生率都随着风险类别的增加而直接上升。在我们的研究中,新的严重程度评分在所有不良事件中似乎具有更高的区分能力,特别是SCAP评分。